Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 08:07 am Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Nantahala Capital Management LLC | 8,513,917 7.5% | 8,513,917 (New Position) | View |
2022-01-19 6:41 pm Purchase | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 50,812,442 43.7% | 1,400,000 (+2.83%) | View |
2021-12-16 4:04 pm Unchanged | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 49,412,442 42.5% | 0 (Unchanged) | View |
2021-11-08 4:05 pm Unchanged | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 49,412,442 43.9% | 0 (Unchanged) | View |
2021-10-14 9:01 pm Purchase | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 49,412,442 43.9% | 412,442 (+0.84%) | View |
2021-09-21 4:51 pm Purchase | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management L.P. | 6,009,696 5.4% | 6,009,696 (New Position) | View |
2021-09-17 3:04 pm Purchase | 13D | AVALO THERAPEUTICS INC AVTX | ARMISTICE CAPITAL LLC | 49,000,000 43.9% | 49,000,000 (New Position) | View |
2021-02-16 06:23 am Purchase | 13G | CERECOR INC CERC | Nantahala Capital Management LLC | 6,233,316 8.3% | 6,233,316 (New Position) | View |
2021-01-12 5:11 pm Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 43,332,442 44.4% | 2,720,000 (+6.70%) | View |
2020-07-31 4:21 pm Sale | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 40,612,442 47.7% | -1,128,000 (-2.70%) | View |
2020-06-11 5:20 pm Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 41,740,442 50.3% | 2,049,486 (+5.16%) | View |
2020-05-07 4:49 pm Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,690,956 56.8% | 127,194 (+0.32%) | View |
2020-04-27 4:30 pm Unchanged | 13G | AYTU BIOSCIENCE INC AYTU | Avalo Therapeutics Inc. AVTX | 0 0% | 0 (Unchanged) | View |
2020-03-19 5:18 pm Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,563,762 58.3% | 1,981,219 (+5.27%) | View |
2020-03-16 5:23 pm Sale | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 37,582,543 55.4% | -3,042,687 (-7.49%) | View |
2020-02-14 4:30 pm Purchase | 13G | CERECOR INC CERC | Opaleye Management Inc. | 2,190,674 4.18% | 5,138 (+0.24%) | View |
2020-02-06 09:58 am Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 40,625,230 59.8% | 1,256,282 (+3.19%) | View |
2019-12-06 4:53 pm Unchanged | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,368,948 63.1% | 0 (Unchanged) | View |
2019-11-07 4:07 pm Unchanged | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,368,948 63.1% | 0 (Unchanged) | View |
2019-09-11 4:55 pm Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,368,948 64.3% | 2,538,948 (+6.89%) | View |